ABCC2 and metabolic disease: Extending these findings, the reversal of dysbiosis and intestinal alterations by inulin underscores its potential as a therapeutic strategy, not only for metabolic disorders but also for restoring the Mrp2-dependent intestinal biochemical barrier.